![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/elpida-elsulfavirine-becomes-the-preferred-first-line-therapy-for-treatment-of-hiv-infection-in-russia-301220399.html
https://www.prnewswire.com/news-releases/viriom-initiates-phase-2-clinical-study-of-elsulfavirine-for-treatment-of-covid-19-301037275.html
https://www.prnewswire.com/news-releases/viriom-launches-reproductive-toxicity-studies-for-elpida-elsulfavirine-once-weekly-oral-formulation-300967876.html
https://www.prnewswire.com/news-releases/viriom-initiates-phase-1-clinical-trial-of-once-monthly-injectable-hiv-treatment-300769370.html